FDMT News - Candlesense

4DMT to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targe...

Investor

5 days ago

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targe...

What is the market’s perception of the company's ability to attract talent with equity incentives? How might this grant affect the company's cash runway and financing needs? Could this grant trigger any additional regulatory or compliance filings?

Employment

15 days ago

4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targ...

How could macro‑economic factors and sector rotation impact 4DMT's stock in the coming weeks? Does the Q2 2025 performance suggest any changes in the company's capital allocation strategy? What are the potential regulatory risks associated with the upcoming milestones mentioned?

Earnings

19 days ago